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 In newly diagnosed Tuberculosis (TB), the diagnosis and therapy duration 
may cause psychological stress requiring effective coping strategy.  
This study aimed to compare and analyze the differences of stress level and 
coping strategy between intensive and advanced phases in newly diagnosed 
TB. This cross-sectional study involved 16 respondents in intensive phase 
and 29 respondents in advanced phase (n=45), in the working area of Pacar 
Keling Public Health Center of Surabaya. Perceived Stress Scale (PSS) and 
coping strategy questionnaire were used for collecting data. Data were 
collected in May 2018. Independent sample t test was used in data analysis 
(α<0.05). Results showed that mostly moderate stress level and adaptive 
coping strategy were found in both phases. Overall, stress and coping were 
not significantly different between phases in newly diagnosed TB  
(p=0.259 and p=0.079 respectively), but the feeling of angry, losing control, 
nervous & depressed, whether things happened as wishes, talking problems 
to professionals, and trying new dangerous thing were differ significantly 
between phases (p=0.046, p=0.024, p=0.044, p=0.016, p=0.014, and p=0.005 
respectively). Although stress level and coping strategy were not 
significantly different between therapeutic phases in newly diagnosed TB, 
but more attention needs to be given towards patients’ emotion, 
 such as the feeling of angry, losing control, nervous and depressed,  
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1. INTRODUCTION  
Tuberculosis (TB) is an infectious disease caused by bacteria of Mycobacterium tuberculosis (M.tb) 
which transmitted through inhaled droplets [1]. Clinical manifestations of TB consist of fever,  
decreased appetite, coughing up phlegm for 3 weeks or more; cough can be followed by phlegm mixed with 
blood, malaise, and shortness of breath [2]. Globally, TB holds the 9
th
 rank of the leading cause of death  
by single infectious agent in 2017. Indonesia ranks second in the highest number of TB cases in the world after 
India [3]. It was estimated that the new cases of TB in Indonesia was 647 cases per 100,000 population.  
In 2016, the top five provinces in Indonesia with the highest number of new TB cases were West Java 
(23,774 cases), East Java (21,606 cases), Central Java (14,139 cases), North Sumatra (11,771 cases),  
and Special Capital Region of Jakarta (9,516 cases). Based on the coverage of TB case findings, the top five 
provinces in Indonesia were West Java (52,328 cases), East Java (45,239 cases), Central Java (28,842 cases), 
Special Capital Region of Jakarta (24,775), and North Sumatra (17,798 cases) [4]. 
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A study from 2008 to 2011 towards 404 clinical specimen from sputum smears TB patients,  
age ≥15 years, which were collected from 16 TB referral primary health centers (PHC) in 16 provincial 
capitals in Indonesia showed that 23% were from the Beijing family, and it was confirmed that the Beijing 
family of M.tb in Indonesia exhibited greater resistance to first line anti-TB drugs than did other families [5]. 
This finding is also consistent with a previous cohort study towards 818 TB cases which proved that  
the Beijing genotype (33.4%) was an independent risk factor for TB treatment failure in Indonesia,  
therefore this genotype has a higher capacity to withstand TB treatment even in the absence of drug 
resistance [6]. Generally, the therapy success rate in Indonesia is 75.4%, which is lower than the World Health 
Organization (WHO) target (85%) and Indonesian Ministry of Health (MoH) target (88%) in 2014 [7]. 
Surabaya is the capital of East Java province. In 2015, the top five cities with most treated TB patients  
in East Java province were Surabaya (4,754 cases), Jember (3,128 cases), Sidoarjo (2,292 cases),  
Malang (1,932 cases), and Pasuruan (1,809 cases) [8]. 
TB can be cured by direct treatment with anti-TB drugs (OAT) for a period of 6 months at least. 
This 6 months period is divided into 2 phases: the first 2 months is considered as intensive phase in which 
most patients experience sputum conversion (from + become -), and the rest 4 months is considered  
as advanced phase aiming at killing persistent M.TB to avoid recurrence [9]. Guidelines of TB therapeutic 
management in Indonesia from Ministry of Health (MOH) stated that for newly diagnosed TB patients,  
first category/line of OAT was given to clinically-diagnosed pulmonary TB patients with or without 
bacteriological contamination. In the intensive phase, TB patients required to eat drugs regularly everyday  
in which family supervision is highly needed to avoid drug resistance [10]. If this phase pasts successfully 
then in a period of 2 weeks after initial treatment the TB patients will not become contagious to others [11]. 
Therefore, intensive phase requires more attention, adherence, and commitment. WHO (2004) has published 
the guidelines of TB treatment to be used as an international standard of TB treatment. There are 4 types  
of drugs need to be consumed everyday regularly in the intensive phase, such as: Isoniazid (Z),  
Rifampicin (R), Pyrazinamide (H), and Ethambutol (E). In comparison, there are 2 types of drugs need  
to be consumed in three-times-a-week basis in advanced phase, such as: Isoniazid (Z) and Rifampicin (R) 
only. Fewer drugs and lower frequency are needed in advanced phase [12].  
TB control success is based on the patient’s compliance to the treatment [13]. Long duration  
of treatment results in non-adherence in TB patients, especially the one with forgetfulness. Non-adherence  
to anti-TB treatment is one of the crucial challenges in improving TB cure rates and reducing further 
healthcare costs [14]. Treatment non-adherence results in treatment failure, prolonged transmission of disease 
and emergence of drug resistance in TB [15].  
Limited treatment options, long duration of treatment, and associated toxicity adversely impact  
the mental well-being, such as stress, in TB patients [16]. TB diagnosis and therapeutic complexity may also 
cause psychological stress in TB patients. Prior study results showed that stress level is strongly correlated 
with coping strategy in newly diagnosed TB patients (ρ = 0.532, p = 0.000) [17]. There is a high possibility 
that the newly diagnosed TB patients experience elevated stress level due to therapeutic complexity 
especially in intensive phase, and it slowly decrease in advanced phase due to fewer drugs consumed and 
lower frequency of drug consumption. This study aimed to compare and analyze the differences of stress 
level and coping strategy between intensive and advanced phases in newly diagnosed TB patients. 
 
 
2. RESEARCH METHOD  
This cross-sectional study involved 45 newly diagnosed TB patients, 16 in intensive phase and 29  
in advanced phase, from Public Health Center (PHC) of Pacar Keling, Surabaya, Indonesia. Inclusion criteria 
were being an adult (> 18 years old) so that they could take the responsibility as study respondent 
independently, TB diagnosis has been confirmed by the PHC, regularly consumed medication based  
on therapeutic regiments from PHC doctor, and had a medication supervisor at home to assure treatment 
adherence. Exclusion criteria were rejection on filling out the consent form, hospitalized in the time of data 
collection, and unclear address (because of door-to-door data collection method). Simple random sampling 
was applied and sample size of 45 was obtained.  
Instrument of Perceived Stress Scale (PSS) by Cohen (1983) was used to measure the stress level [18]. 
It consisted of 10 items in five responses Likert scale format (0-4). The items were (1) feeling of angry,  
(2) losing control, (3) nervous and depressed, (4) self-efficacy towards personal problem solving ability,  
(5) whether things happened as wishes, (6) inability to finish assigned work, (7) manage sensitive feeling,  
(8) ability to solve personal problems, (9) angry towards unsolved problems, and (10) feeling of accumulated 
difficulties resulted in inability to solve them. Stress level was categorized into three based on the total score: 
mild (0-13), moderate (14-27), and severe stress (28-40). Actually there are some conditions which 
potentially influence individual stress level, such as pregnancy, physical or psychological disease  
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(HIV, adrenal or mental disorders, depression, etc.), but this instrument may be applied generally to any 
person in any condition. Cohen (1983) did not specified the target population of this PSS. The wide exclusion 
criteria in this study context may become the study limitation.  
Researchers developed a questionnaire to measure coping strategy in TB patients based  
on the domains proposed by Stuart & Sundeen (2007) [19] in combination with Carver (1989) [20].  
It consisted of 12 items in four responses Likert scale format (1-4). The items were (1) self-blaming due  
to inability to maintain health status, (2) ability to take advantages from personal problems, (3) wishful 
thinking in facing problems due to the disease, (4) talking problems to professionals, (5) trying new 
dangerous thing at home, (6) escaping from others due to the disease, (7) enjoying life under difficult 
circumstances, (8) keeping sickness as a secret from others, (9) praying and stay close to God,  
and (10) feeling desperate towards treatment, (11) eliminating stress by sleeping and doing nothing,  
(12) feeling angry and blaming others due to the problems. Coping strategy was categorized into two: 
adaptive (31-48) and maladaptive coping strategy (12-30).  
A preliminary study towards 30 respondents which conducted in the working area of Kedungdoro 
PHC, Surabaya, in April 2018 showed that PSS and the coping strategy questionnaire were valid and reliable 
instruments (PSS: r=0.410-0.772, Chronbach Alpha=0.820; coping strategy questionnaire: r = 0.081-0.839, 
Chronbach Alpha = 0.897) [21]. Data were collected in May 2018. Prior to data collection process, this study 
protocol has been reviewed by Faculty of Nursing, Widya Mandala Catholic University Surabaya,  
and informed consent preceded participation. Descriptive statistic and independent sample t test were used  
in data analysis (α<0.05). 
 
  
3. RESULTS AND ANALYSIS  
Stress is a physical and psychological response towards physical, social, and psychological stressors 
resulted in tension and daily life stability disturbance [22]. Stress has an impact in physically ill individual due 
to the weakness and slow response of the immune system by the time it happens [23]. There are various factors 
affecting stress response internally and externally, such as: age, gender, personality, cognitive function,  
family situation, physical and social environment, disease and treatment duration [24]. In stress condition, 
human body will give a response physiologically by mechanism: immune system is stimulated by various 
stressors affecting PVN (paraventricular nucleus), then the neurons will synthesize corticotropin releasing 
hormone (CRH) and arginine vasopressin (AVP) stimulating the adrenocorticotropin hormone (ACTH) which 
releases the glucocorticoids and cortisol hormone for the process of coping with stressors [25].  
Stress manifestation could be seen in physical, emotional, cognitive, and behavioral symptoms [23]. 
 Coping is an individual way to solve problems, adjusting to changes, and responding towards 
threatening situation [26]. Coping mechanism is the way a person adjusts to a stressor psychologically, 
physically, and behaviorally; this is someone's ability to deal with problems and stress consciously [27]. 
Effective coping to do is a coping to help all people to tolerate and accept stressful situations [28]. Stuart and 
Sundeen (2007) categorized coping into two types: adaptive and maladaptive coping strategy [19].  
Adaptive coping consisted of active coping, social support seeking behavior, positive reinterpretation,  
self-control, planning, situational acceptance, religious coping, and humor. In the other hand,  
maladaptive coping consisted of refusal, chemical substance usage, emotional social support seeking behavior, 
behavioral loose, emotional-focused behavior, mental loose, and emphasis to compete. There are various factors 
affecting coping, such as: age, gender, educational level, marital status, and social support [28, 29].  
Table 1 explains the demography characteristic of study respondents in details. Most respondents were married 
male pre-elderly with sufficient educational background which still working as a private employee.  
In this study, most respondents were aged 56-65 years old (24.44%) that is considered as pre-elderly  
to elderly population. Elderly without TB experience somatic, cultural, and economical stress due to physical, 
psychological, and social changes; while the presence of TB worsen the stress condition because of its clinical 
manifestation and treatment. Age is not only influence the stress level, but also the coping strategy. The stressor 
experienced by each stage of life represented by age differences was varied due to variation in demands,  
life challenges, experiences, preferences, personal values and beliefs, etc. Siswanto (2007) stated that age can  
be related with individual stress tolerance and the most disturbing type of stressor [29].  
In this study, most respondents were males (57.78%). Males and females have different tendency  
in responding stressors. Males tend to implement fight-or-flight technique while females tend to implement 
tend-and-befriend technique [30]. Males seemed to prefer confrontation, while females seemed to prefer 
withdrawal or escape. Differences in stress response between males and females are closely related to hipofisis-
pituitary-adrenal (HPA) axis activities by regulating cortisol hormone and sympathetic nervous system 
associated with heart rate and blood pressure. The HPA axis and autonomic nervous responses are found higher 
in adult males compared to adult females resulted in performance differences in responding the stressors [31]. 
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Table 1. Demography characteristic 
Characteristic Frequency Percentage 










































4. Education level 
a. Primary school 
b. Secondary school  
c. High school 














c. Entrepreneur  













Most respondents in this study were high school graduated (64.44%). Educational background 
affects individual stressor control, the higher the educational background then the better the stress tolerance 
and stressor control [29]. High educational level makes individual has broader perspective about everything 
in life, higher knowledge possessed makes someone accepts new ideas or life ways easily and tend to 
implement more adaptive coping strategy. Low educational level resulted in intellectual limitation so that 
behavior or stress response still influenced by environmental situation and there will be a tendency of 
maladaptive coping strategy implemented [32]. Marital status implicates family support, medication 
supervisor, and housing social environment in this study context. Most respondents in this study are married 
(73.33%), and spouse became the medication supervisor at home as shown in Table 2 (57.78%). Marital 
status is reported to be associated with adherence to anti-TB treatment [33]. Non-adherence to TB treatment 
was high if the patients had forgetfulness [14]. Therefore the role of medication supervisor is very important 
because she reminds and motivates TB patients to follow the regiments correctly and persistently. Family can 
provide informational, instrumental, financial, and emotional support towards each other [29].  
Primary data in this study context consisted of the time of first TB diagnosis, treatment duration,  
anti-TB drug consumption, and the medication supervisor at home. Table 2 explains the primary data  
of study respondents in details. Most respondents were diagnosed with TB since November 2017-January 
2018 (44.44%) and in May 2018 they were in advanced phase (64.44%) with mostly 5-6 months treatment 
duration (48.89%). The OAT consumed by most respondents was RH (Rifampicin+Pyrazinamide) [55.56%].  
 
 
Table 2. Primary data 
Characteristic Frequency Percentage 
1. Firstly diagnosed 
a. February – April 2018 
b. November 2017 – January 2018 
c. August - October 2017 











2. Treatment duration (months) 
a. 1-2 (intensive phase) 
b. 3-4 (advanced phase) 









3. Drugs consumed  
a. RHZE 
b. RH 
c. RH + Ethambutol  
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TB can be cured by long treatment duration, at least 6 months [9]. Mumpuni (2010) stated that long 
treatment duration resulted in psychological stress with frustration being one of the symptoms [23].  
Table 3 explains the comparison of stress level and coping strategy between intensive and advanced phase  
in newly diagnosed TB patients. These results indicated that whether most respondents experienced moderate 
level of stress but they could manage it well by implementing adaptive coping strategy. This potentially 
resulted in better therapeutic outcome, such as sputum conversion in the end of intensive phase and 
avoidance of TB recurrence in the end of advanced phase.   
 
 
Table 3. Measured variables 
Characteristic 
Intensive phase (n=16) Advanced phase (n=29) 
Frequency Percentage Frequency Percentage 





































The majority of respondents experienced moderate stress level in intensive and advanced phases 
(62.5% and 75.86% respectively), and there was no significant difference of stress level between both phases  
in newly diagnosed TB patients (p=0.259). This result was supported by a study of Chilyatiz and Subai’ah 
(2016) which found that most of newly diagnosed TB patients who got 1
st
 line of OAT experienced moderate 
stress level (63%) [34]. Iqra, et al. (2016) also found that most of newly diagnosed TB patients who got 1
st
 
line of OAT experienced moderate stress level (86.2%) [35]. Both studies did not differentiate  
the respondents into intensive and advanced phases like in this study context, but their results were similar  
in general. 
Overall, stress level between therapeutic phases was not significantly different in newly diagnosed 
TB patients. But, deeper analysis of independent sample t test towards each item of PSS showed that  
the feeling of angry, losing control, nervous & depressed, and whether things happened as wishes were 
differs significantly between phases (p=0.046, p=0.024, p=0.044, and p=0.016 respectively). Results showed 
that various emotions existed during TB treatment. There is no specific study in TB patients about their 
emotion during TB treatment. This is important to predict stress level determinant, especially in newly 
diagnosed TB patients. In the other hand, few studies about depression and other common mental disorder 
has been studied in TB context, especially in multi-drug-resistant TB patients. Mental disorders,  
such as depression, might contribute to the burden of TB as a chronic disease. There appears to be a positive 
and independent association between common mental disorders and TB [36]. Depressive disorders have been 
negatively associated with compliance of therapeutic schemes for chronic diseases generally.  
Depression could be a hazard factor for negative outcomes in TB patients receiving treatment,  
including abandon or death [13].  
Study about correlation between angriness and stress in TB is not found online yet.  
But Mycobacterium tuberculosis sigF is proved to be an alternative sigma factor implicated in stress  
response [37]. A study in another context, recurrent aphthous stomatitis (RAS), showed that among subjects 
with high angriness or anxiety, RAS subjects showed higher stress level. Therefore anger/anxiety level 
mediates the relationship between stress level and RAS [38]. In this study, we found that angriness differ 
significantly between intensive and advanced phases in newly diagnosed TB. This potentially happened due  
to the significant difference in therapy duration. As shown in Table 2, intensive phase only occurs for the first 
two months, while the advanced phase occurs in month 3-6. Therefore, respondents in advanced phase 
experienced longer therapy duration so that the angriness response also higher, and this reflects higher  
stress level.  
Feeling nervous and depressed are two negative emotional constructs found in TB patients.  
The study about nervous and TB is not found online yet. Oppositely, there are various studies about 
depression in TB patients. The prevalence of depression is high in TB patients currently on DOTS or TB 
therapy [39]. Depression has adverse effect on TB treatment and drug compliance. Depression is also 
prevalent among hospitalized TB patients, especially young or elderly male, which caused by altered social 
relationship or TB stigma in female [40]. A study towards 84 subjects who were initially diagnosed with TB 
showed that TB stigma together with body mass index were accounted for 34% of the variation 
 in depression [41]. In this study, depression was significantly different between therapeutic phases.  
This potentially happened due to altered social relationship or TB stigma which is more possible to happen  
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in the advanced phase compared to intensive phase. Another study towards 648 TB patients under treatment 
showed that if depression was untreated then the result will be worse treatment outcomes, poorer quality  
of life, and greater disability [42]. Therefore, health care professional needs to pay more attention  
to depression in TB patients under treatment, especially in those under advanced phase.  
Patients’ wishes related to TB treatment are mostly studied in qualitative paradigm. A qualitative 
study in Japan towards 11 public health nurses (PHNs) revealed that when patients became discouraged, 
PHNs listened to patients' wishes regarding drug adherence and hospitalization, and they tailored treatment 
accordingly, recognizing and respecting patient independence, and involving patients' natural support system 
to assist in treatment adherence [43]. In this study, patients’ wishes were significantly different between 
therapeutic phases. But, we did not conduct any interview towards study respondents, so that this aspect 
remains unclear. There is a possibility that patients’ wishes become more realistic in those under advanced 
phase because they were experienced with DOTS treatment and better understand the treatment goals.   
Most of respondents implemented adaptive coping strategy in both therapeutic phases (68.75% and 
93.10% for intensive and advanced phases respectively), and there was no significant difference of coping 
strategy between phases in newly diagnosed TB patients (p=0.079). This result was supported by a study  
of Gilang & Zaenal (2016) which found that under-treatment TB patients were mostly implemented adaptive 
coping strategy (86.2%) due to family support [44]. But, this study also did not differentiate the respondents 
into intensive and advanced phases, and family support may be seen as medication supervisor in this study 
context as shown in Table 2 in which spouse being the most involved person in DOTS monitoring at home.  
Overall, coping strategy between therapeutic phases was not significantly different in newly 
diagnosed TB patients. Deeper analysis of independent sample t test towards each item of coping strategy 
questionnaire showed that talking problems to professionals and trying new dangerous thing were also differs 
significantly between phases (p=0.014 and p=0.005 respectively). Talking problems to health professionals 
could be done by face to face meeting or using means of telecommunication devices, such as mobile phone, 
email, social media, etc. For face to face meeting, there are some barriers becoming challenges,  
such as the distance to health institution, financial capacity, means of transportation, family support  
to become a company, etc. Feeling distance to health institution is long and waiting time > 1 hour during 
service were found to be determinants of non-adherence to TB treatment [45]. Related to depression,  
the new dangerous thing meant in this context includes suicide. Depression could be a hazard factor for death 
in TB patients receiving treatment [13]. Therefore psychological counseling and educational interventions 
could be beneficial for improving treatment adherence in TB patients [15]. 
 
 
4. CONCLUSION  
Moderate stress level and adaptive coping strategy was mostly found in newly diagnosed TB 
patients, both in intensive and advanced phase of TB treatment. Stress level and coping strategy between both 
therapeutic phases were not significantly different. More attention needs to be given towards the feeling  
of angry, losing control, nervous & depressed, and patients’ wishes in intensive phase result in stress during 
treatment. Those in intensive phase need more assistance and consultation from professionals due to less 
communication about health problems with professional and the tendency to try new dangerous thing during 
treatment. Health care proffessional are reccommended to provide sufficient time for doing individual 
consultation during intensive phase of treatment so that the psychological and emotional needs of TB patients 
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